September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Interferon alpha2a and systemic corticosteroids in monotherapy in chronic bilateral autoimmune posterior uveitis associated with macular edema: results of the randomised controlled BIRDFERON study
Author Affiliations & Notes
  • Christine Fardeau
    Ophthalmology department, Reference Centre for Rare Diseases, Pitié-Salpétrière Hospital, University Paris VI, DHU Sight Restore, Paris, France
  • Anne Simon
    department of Internal Medicine, Pr S. Herson, Pitié-Salpétrière Hospital, Paris, France
  • benoit Rodde
    department of Psychiatry, Pitié-Salpétrière Hospital, Paris, France
  • Fabiana Viscogliosi
    Ophthalmology department, Reference Centre for Rare Diseases, Pitié-Salpétrière Hospital, University Paris VI, DHU Sight Restore, Paris, France
  • Pierre Labalette
    department of Ophthalmlogy, Universitary Hospital, Lille, Lille, France
  • Vincent Looten
    Department of Biostatistics Public Health and Medical Informatics, Pitié-Salpétrière Hospital, University Paris VI, Paris, France
  • Sophie Tézenas du Montcel
    Department of Biostatistics Public Health and Medical Informatics, Pitié-Salpétrière Hospital, University Paris VI, Paris, France
  • Phuc LeHoang
    Ophthalmology department, Reference Centre for Rare Diseases, Pitié-Salpétrière Hospital, University Paris VI, DHU Sight Restore, Paris, France
  • Footnotes
    Commercial Relationships   Christine Fardeau, None; Anne Simon, None; benoit Rodde, None; Fabiana Viscogliosi, None; Pierre Labalette, None; Vincent Looten, None; Sophie Tézenas du Montcel, None; Phuc LeHoang, None
  • Footnotes
    Support  funded by the Health Ministry and sponsored by Assistance Publique des Hôpitaux de Paris, Fr.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1895. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Christine Fardeau, Anne Simon, benoit Rodde, Fabiana Viscogliosi, Pierre Labalette, Vincent Looten, Sophie Tézenas du Montcel, Phuc LeHoang; Interferon alpha2a and systemic corticosteroids in monotherapy in chronic bilateral autoimmune posterior uveitis associated with macular edema: results of the randomised controlled BIRDFERON study. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1895.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Purpose : Macular edema is the main leading cause of vision loss in bilateral chronic non-infectious posterior uveitis. The systemic route is often used with corticosteroids, conventional immunosuppressive agents and biotherapies, including interferon (IFN)-α. The aim of this phase II trial was to assess and compare the efficacy and safety of corticosteroids and IFN-α in monotherapy in adults with such conditions.

Methods : Methods : In this open-label, randomized, parallel-arm trial, patients received either subcutaneous IFN-α2a, systemic corticosteroids or no treatment for 4 months. The efficacy and safety were assessed for up to 4 months. Adult patients with bilateral posterior autoimmune non-infectious and non-tumoral uveitis complicated by ME in at least one eye, were recruited. Patients were randomized to receive either subcutaneous IFN-α2a (IFN-α group), systemic corticosteroids (corticosteroid group) or no treatment (control group) for 4 months. The main endpoint was the change of the central foveal thickness (CFT) measured on the retinal mapping obtained by optical coherence tomography.

Results : Results : Forty-eight patients were included. In intention-to-treat analysis, the median CFT change showed no significant difference in the global test. However, the per protocol analysis showed a significant difference for both eyes (OD and OS), and for the worst and best eyes. Statistically significant difference was found between the control and corticosteroid groups for the OD (p=0.0285), and between the control and IFN-α groups for the OD (p=0.0424) and worst eye (p=0.0354). No difference was found between the corticosteroid and IFN-α groups regardless of the ocular feature. A significant increase ≥15 ETDRS letters was found in the global test only for the worst eye (p=0.0137). Three cases with serious adverse events resolved after treatment cessation.

Conclusions : Conclusions : In patients with chronic uveitic macular edema, IFN-α and systemic corticosteroids, compared to no treatment, were associated with significant anatomic and functional macular improvement.
None conflict of interest to disclose (funded by the Health Ministry and sponsored by Assistance Publique des Hôpitaux de Paris, ClinicalTrials.gov: NCT00508040).

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×